Bruker BioSpin's MRI CryoProbe(TM) Selected for 2008 R&D 100 Award for Enabling Preclinical MRI on Mice at 60 Micrometer Spatial

  
    
  
  
    
      A prestigious 2008 R&D 100 Award has been given to Bruker BioSpin for 
      the MRI CryoProbe™, as one of the 100 most 
      technologically significant products introduced into the marketplace 
      over the past year. Together with the 1.7 mm NMR MicroCryoProbe, this 
      results in two magnetic resonance innovations from Bruker BioSpin being 
      selected by the independent judging panel and editors of R&D Magazine in 
      2008.
    
    
      The Magnetic Resonance Imaging (MRI) CryoProbe™ 
      delivers an increase in sensitivity of approximately a factor of 2.5x in 
      small animal in vivo MRI. This enables very high 3D isotropic 
      spatial resolution down to 60 µm, or 
      alternatively an increase in acquisition speed by more than a factor of 
      5x compared to conventional room temperature MRI RF coils. In 
      combination with high magnetic fields, the MRI CryoProbe enables new 
      pre-clinical neuroscience studies with functional MRI (fMRI).
    
    
      Bruker BioSpin’s MRI CryoProbe technology uses 
      cryogenic RF-coils and preamplifiers cooled by a closed-cycle helium gas 
      refrigeration system. Bruker BioSpin is the pioneer in the development 
      of cryogenic probes for high-resolution NMR. Over 650 Bruker NMR 
      CryoProbes have been installed at customers worldwide so far. The new 
      MRI CryoProbe is available for in vivo animal MRI at various 
      field strengths for BioSpec®, 
      PharmaScan® and 
      ClinScan® MRI 
      scanners.
    
    
      Comprehensive animal studies using the MRI CryoProbe were performed at 
      the ETH in Zuerich, Switzerland, where it is routinely used for clinical 
      neuroscience research on mice. Professor Markus Rudin, Director of the 
      MRI and Optical Imaging Section of the Animal Imaging Center, ETH 
      Zuerich, commented: “This novel MRI CryoProbe 
      technology has proven to provide a strong and impressive increase in 
      sensitivity. It will greatly enhance the potential of MRI in small 
      animals for clinical and pharmaceutical research.”
    
    
      ABOUT BRUKER BIOSPIN: For more information about Bruker BioSpin 
      and Bruker Corporation (NASDAQ: BRKR), please visit www.bruker-biospin.com 
      and www.bruker.com.